144 related articles for article (PubMed ID: 36133914)
1. Expression and Significance of Cyclin-Dependent Protein Kinase 6 in Diffuse Large B-Cell Lymphoma.
Li J; Li P; Su H; Feng H; Bai Z; Xi Y
Int J Gen Med; 2022; 15():7265-7276. PubMed ID: 36133914
[TBL] [Abstract][Full Text] [Related]
2. [Expression of CDK6 and FOXM1 in peripheral T-cell lymphoma and their significance].
Feng HN; Shao XX; Bu P; Zhang F; Wang YJ; Xi YF; Guo WN
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):594-600. PubMed ID: 32486537
[No Abstract] [Full Text] [Related]
3. CDK6 overexpression resulted from microRNA‑320d downregulation promotes cell proliferation in diffuse large B‑cell lymphoma.
Su H; Chang J; Xu M; Sun R; Wang J
Oncol Rep; 2019 Jul; 42(1):321-327. PubMed ID: 31059102
[TBL] [Abstract][Full Text] [Related]
4. [The Expression and Correlation of
Li Y; Liu XY; Cui GR; Kong XY; Yang L; Luo JM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):120-124. PubMed ID: 36765487
[TBL] [Abstract][Full Text] [Related]
5. Identification of ATP1B1, a key copy number driver gene in diffuse large B-cell lymphoma and potential target for drugs.
Zhang S; Wang H; Liu A
Ann Transl Med; 2022 Oct; 10(20):1136. PubMed ID: 36388804
[TBL] [Abstract][Full Text] [Related]
6. High expression of cell division cycle 7 protein correlates with poor prognosis in patients with diffuse large B-cell lymphoma.
Hou Y; Wang HQ; Ba Y
Med Oncol; 2012 Dec; 29(5):3498-503. PubMed ID: 22528513
[TBL] [Abstract][Full Text] [Related]
7. [Expressions and Clinical Significance of Notch1 and Hes1 in Diffuse Large B-Cell Lymphoma].
Liu Y; Xu SS; Wang XN; Zheng N; Xu MY; Li J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):714-721. PubMed ID: 37356931
[TBL] [Abstract][Full Text] [Related]
8. RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.
Xu C; Liang T; Liu J; Fu Y
Front Pharmacol; 2022; 13():931501. PubMed ID: 35910358
[No Abstract] [Full Text] [Related]
9. Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma.
Cui W; Cai Y; Wang W; Liu Z; Wei P; Bi R; Chen W; Sun M; Zhou X
J Transl Med; 2014 Jan; 12():10. PubMed ID: 24418330
[TBL] [Abstract][Full Text] [Related]
10. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
Front Immunol; 2022; 13():950213. PubMed ID: 36072582
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of miR-23a and MTSS1 in diffuse large B-cell lymphoma.
Xu M; Xu T
Oncol Lett; 2018 Jul; 16(1):371-377. PubMed ID: 29928423
[TBL] [Abstract][Full Text] [Related]
12. [Expression of MicroRNA-26a and Its Target Gene CDK6 in Extra-nodal NK/T-Cell Lymphoma].
Huang JX; Wu YA; He YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1021-5. PubMed ID: 26314438
[TBL] [Abstract][Full Text] [Related]
13. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247
[No Abstract] [Full Text] [Related]
14. ICT1 predicts a poor survival and correlated with cell proliferation in diffuse large B-cell lymphoma.
Xie W; Wu M; Fu T; Li X; Wang Z; Hu Y; Zhu L; Zhang G
Gene; 2017 Sep; 627():255-262. PubMed ID: 28629825
[TBL] [Abstract][Full Text] [Related]
15. Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma.
Cao B; Guo X; Huang L; Wang B; Wang W; Han D; Zhang W; Zhong K
Aging (Albany NY); 2021 Jul; 13(13):17768-17788. PubMed ID: 34252883
[TBL] [Abstract][Full Text] [Related]
16. Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics.
Zhang YA; Yang X; Yao J; Ren Y; Liu P
Dis Markers; 2022; 2022():3276925. PubMed ID: 35774848
[TBL] [Abstract][Full Text] [Related]
17. Expression of exportin-1 in diffuse large B-cell lymphoma: immunohistochemistry and TCGA analyses.
Luo B; Huang L; Gu Y; Li C; Lu H; Chen G; Peng Z; Feng Z
Int J Clin Exp Pathol; 2018; 11(12):5547-5560. PubMed ID: 31949642
[TBL] [Abstract][Full Text] [Related]
18. LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
Peng W; Wu J; Feng J
Clin Exp Med; 2017 Feb; 17(1):1-8. PubMed ID: 26475621
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma.
Pan PJ; Liu JX
World J Clin Cases; 2021 Aug; 9(22):6287-6299. PubMed ID: 34434995
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
Luo B; Gu YY; Wang XD; Chen G; Peng ZG
Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
